Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women

Código QR

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women

Guardado en:

Detalles Bibliográficos
Autores principales:	Per Eriksson, Karin Leander, Bruna Gigante, Yasmin Miri, Louise Ziegler
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/dd343157c1c6413e86e6f533a3e3bdd1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Shahnam Sharif, et al.
Publicado: (2021)

Traditional cardiovascular risk factors are associated with adverse cardiac events in pregnant women with elevated right ventricular systolic pressure
por: William Marshall, et al.
Publicado: (2021)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
por: Linda R. Peterson, et al.
Publicado: (2018)

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Zuoan Qin, et al.
Publicado: (2021)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19
por: Mehmet Erdoğan, et al.
Publicado: (2021)

Cerebrovascular ischemic event - what about the coronaries
por: Joseph C. Lee, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
por: Amelia Carro, et al.
Publicado: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
por: Ahmed Zwain, et al.
Publicado: (2021)

Effects of aerospace environments on the cardiovascular system
por: Erdinç Ercan
Publicado: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021)

Valve disease and aortopathy associations of bicuspid aortic valve phenotypes differ between men and women
por: Anders Franco-Cereceda, et al.
Publicado: (2021)

Blood pressure, autonomic stress, and inflammatory markers during sleep deprivation and recovery in healthy men
por: Özge Bozer, et al.
Publicado: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Aortic distensibility in Marfan syndrome: a potential predictor of aortic events?
por: Aeilko H Zwinderman, et al.
Publicado: (2021)

The Future of Telemedicine in the Management of Heart Failure Patients
por: José Silva-Cardoso, et al.
Publicado: (2021)

Outcomes After Percutaneous Coronary Intervention in Women: Are There Differences When Compared with Men?
por: Usha Rao, et al.
Publicado: (2019)

Men are from Mars, women are from Venus: female hearts break easier than male from sadness
por: Dimitri Richter
Publicado: (2021)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
por: Yunqiu Jiang, et al.
Publicado: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
por: Sotirios Tsalamandris, et al.
Publicado: (2019)

Below-the-ankle Angioplasty: Current Evidence and Future Perspectives
por: Stavros Spiliopoulos, et al.
Publicado: (2019)